300 related articles for article (PubMed ID: 29551673)
1. CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells.
Lupia M; Angiolini F; Bertalot G; Freddi S; Sachsenmeier KF; Chisci E; Kutryb-Zajac B; Confalonieri S; Smolenski RT; Giovannoni R; Colombo N; Bianchi F; Cavallaro U
Stem Cell Reports; 2018 Apr; 10(4):1412-1425. PubMed ID: 29551673
[TBL] [Abstract][Full Text] [Related]
2. CD73 is associated with poor prognosis in high-grade serous ovarian cancer.
Turcotte M; Spring K; Pommey S; Chouinard G; Cousineau I; George J; Chen GM; Gendoo DM; Haibe-Kains B; Karn T; Rahimi K; Le Page C; Provencher D; Mes-Masson AM; Stagg J
Cancer Res; 2015 Nov; 75(21):4494-503. PubMed ID: 26363007
[TBL] [Abstract][Full Text] [Related]
3. A preliminary study of the role of extracellular -5'- nucleotidase in breast cancer stem cells and epithelial-mesenchymal transition.
Yu J; Liao X; Li L; Lv L; Zhi X; Yu J; Zhou P
In Vitro Cell Dev Biol Anim; 2017 Feb; 53(2):132-140. PubMed ID: 27670764
[TBL] [Abstract][Full Text] [Related]
4. L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling.
Giordano M; Decio A; Battistini C; Baronio M; Bianchi F; Villa A; Bertalot G; Freddi S; Lupia M; Jodice MG; Ubezio P; Colombo N; Giavazzi R; Cavallaro U
J Exp Clin Cancer Res; 2021 Oct; 40(1):319. PubMed ID: 34645505
[TBL] [Abstract][Full Text] [Related]
5. CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder Cancer.
Cao L; Bridle KR; Shrestha R; Prithviraj P; Crawford DHG; Jayachandran A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163489
[TBL] [Abstract][Full Text] [Related]
6. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis.
Ma XL; Shen MN; Hu B; Wang BL; Yang WJ; Lv LH; Wang H; Zhou Y; Jin AL; Sun YF; Zhang CY; Qiu SJ; Pan BS; Zhou J; Fan J; Yang XR; Guo W
J Hematol Oncol; 2019 Apr; 12(1):37. PubMed ID: 30971294
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of NT5E/CD73 in neuroblastoma and its function in CSC stemness maintenance.
Jain D; Somasundaram DB; Aravindan S; Yu Z; Baker A; Esmaeili A; Aravindan N
Cell Biol Toxicol; 2023 Jun; 39(3):967-989. PubMed ID: 34773529
[TBL] [Abstract][Full Text] [Related]
8. CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.
Gao ZW; Wang HP; Lin F; Wang X; Long M; Zhang HZ; Dong K
BMC Cancer; 2017 Feb; 17(1):135. PubMed ID: 28202050
[TBL] [Abstract][Full Text] [Related]
9. CD73 as a therapeutic target for pancreatic neuroendocrine tumor stem cells.
Katsuta E; Tanaka S; Mogushi K; Shimada S; Akiyama Y; Aihara A; Matsumura S; Mitsunori Y; Ban D; Ochiai T; Kudo A; Fukamachi H; Tanaka H; Nakayama K; Arii S; Tanabe M
Int J Oncol; 2016 Feb; 48(2):657-69. PubMed ID: 26691441
[TBL] [Abstract][Full Text] [Related]
10. Autocrine Adenosine Regulates Tumor Polyfunctional CD73
Gourdin N; Bossennec M; Rodriguez C; Vigano S; Machon C; Jandus C; Bauché D; Faget J; Durand I; Chopin N; Tredan O; Marie JC; Dubois B; Guitton J; Romero P; Caux C; Ménétrier-Caux C
Cancer Res; 2018 Jul; 78(13):3604-3618. PubMed ID: 29559470
[TBL] [Abstract][Full Text] [Related]
11. CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma.
Ma XL; Hu B; Tang WG; Xie SH; Ren N; Guo L; Lu RQ
J Hematol Oncol; 2020 Feb; 13(1):11. PubMed ID: 32024555
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of stem-like cells from a human ovarian cancer cell line.
Wang L; Mezencev R; Bowen NJ; Matyunina LV; McDonald JF
Mol Cell Biochem; 2012 Apr; 363(1-2):257-68. PubMed ID: 22160925
[TBL] [Abstract][Full Text] [Related]
13. Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody-Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function.
Jin R; Liu L; Xing Y; Meng T; Ma L; Pei J; Cong Y; Zhang X; Ren Z; Wang X; Shen J; Yu K
Mol Cancer Ther; 2020 Nov; 19(11):2340-2352. PubMed ID: 32943546
[TBL] [Abstract][Full Text] [Related]
14. Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.
Häusler SF; Montalbán del Barrio I; Strohschein J; Chandran PA; Engel JB; Hönig A; Ossadnik M; Horn E; Fischer B; Krockenberger M; Heuer S; Seida AA; Junker M; Kneitz H; Kloor D; Klotz KN; Dietl J; Wischhusen J
Cancer Immunol Immunother; 2011 Oct; 60(10):1405-18. PubMed ID: 21638125
[TBL] [Abstract][Full Text] [Related]
15. CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer.
Petruk N; Tuominen S; Åkerfelt M; Mattsson J; Sandholm J; Nees M; Yegutkin GG; Jukkola A; Tuomela J; Selander KS
Sci Rep; 2021 Mar; 11(1):6035. PubMed ID: 33727591
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of CD73 Confers Acquired Radioresistance and is Required for Maintaining Irradiation-selected Pancreatic Cancer Cells in a Mesenchymal State.
Nguyen AM; Zhou J; Sicairos B; Sonney S; Du Y
Mol Cell Proteomics; 2020 Feb; 19(2):375-389. PubMed ID: 31879272
[TBL] [Abstract][Full Text] [Related]
17. Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.
Dietrich F; Figueiró F; Filippi-Chiela EC; Cappellari AR; Rockenbach L; Tremblay A; de Paula PB; Roesler R; Filho AB; Sévigny J; Morrone FB; Battastini AMO
J Cancer Res Clin Oncol; 2018 Mar; 144(3):469-482. PubMed ID: 29305710
[TBL] [Abstract][Full Text] [Related]
18. Ecto-5'-nucleotidase (CD73) is a biomarker for clear cell renal carcinoma stem-like cells.
Song L; Ye W; Cui Y; Lu J; Zhang Y; Ding N; Hu W; Pei H; Yue Z; Zhou G
Oncotarget; 2017 May; 8(19):31977-31992. PubMed ID: 28404888
[TBL] [Abstract][Full Text] [Related]
19. CD73 is associated with poor prognosis in HNSCC.
Ren ZH; Lin CZ; Cao W; Yang R; Lu W; Liu ZQ; Chen YM; Yang X; Tian Z; Wang LZ; Li J; Wang X; Chen WT; Ji T; Zhang CP
Oncotarget; 2016 Sep; 7(38):61690-61702. PubMed ID: 27557512
[TBL] [Abstract][Full Text] [Related]
20. Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer.
Allard B; Turcotte M; Stagg J
Expert Opin Ther Targets; 2014 Aug; 18(8):863-81. PubMed ID: 24798880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]